Investec maintains a bullish stance on Cipla, expecting 12-13% sales growth in the Indian pharma market and clearance of its Goa plant by the US FDA in a few months, paving the way for the production of Abraxane, a key drug in Cipla's pipeline. Investec retains its 'buy' call with a price target of Rs 1,900, implying a 15% upside potential.
Open FlipShares of newly listed Bajaj Housing Finance will be in focus on Friday after the company released its first business update for the July-September quarter, marking its debut as a public company. In the update, Bajaj Housing Finance reported that its Assets Under Management (AUM) surpassed Rs 1 lakh crore during the quarter, reaching Rs 1,02,550 crore—a 26% growth compared to Rs 81,215 crore.
Open FlipGeojit Financial Services's report on Daily Agri Picks. Farmers in Karnataka have sown kharif crops over 8.1 million hectares as of last Friday, up 9.4% from 7.4 million hectares sown a year ago, according to a report released by the state's agricultural department. The normal kharif acreage for the period, which is the average of the last five years, is 7.6 million hectares.
Open Flip